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Introduction
Phosphatidylinositol  (PI)  4,5-bisphosphate  (PI(4,5)P2)  and 
PI 3,4,5-triphosphate (PI(3,4,5)P3) are two phosphoinositides 
concentrated at the plasma membrane that play major regu-
latory roles in a variety of cellular functions. Their levels are 
tightly controlled by kinases, phosphatases, and phospholipases 
(Di Paolo and De Camilli, 2006; Vicinanza et al., 2008). Some 
phosphatases not only control cell surface–associated levels of 
these phosphoinositides but also couple endocytosis to their 
dephosphorylation, thus ensuring their preferential or selective 
retention at the plasma membrane. More specifically, synapto-
janin 1 and 2, as well as OCRL (oculocerebrorenal syndrome 
of Lowe) and INPP5B, all contain an inositol 5-phosphatase 
domain, bind endocytic proteins, and are found at early stages 
of the endocytic pathway (McPherson et al., 1996; Shin et al., 
2005; Hyvola et al., 2006; Perera et al., 2006; Erdmann et al., 
2007). Additionally, synaptojanin 1 and OCRL, which contain 
binding sites for clathrin’s heavy chain and its adaptor AP-2, 
are recruited to endocytic clathrin-coated pits (CCPs; Perera et al., 
2006; Erdmann et al., 2007; Choudhury et al., 2009; Mao et al., 
2009). Studies of these enzymes, as well as evidence for the 
critical role of PI(4,5)P2 in the recruitment to the plasma mem-
brane of endocytic clathrin adaptors and their accessory factors, 
led to the now well-established concept that PI(4,5)P2 plays an 
important role in CCP dynamics (Cremona et al., 1999; Haucke, 
2005; Di Paolo and De Camilli, 2006; Zoncu et al., 2007) in ad-
dition to its classical signaling roles.
Endocytic clathrin adaptors also bind PI(3,4,5)P3 (Hao   
et al., 1997; Rapoport et al., 1997; Gaidarov and Keen, 1999; 
Itoh et al., 2001), an important mediator of the actions of insulin 
and other growth factors. Furthermore, inositol 5-phosphatases 
known to be located at endocytic CCPs, namely synaptojanin 
P
hosphatidylinositol (PI) 4,5-bisphosphate (PI(4,5)P2) 
and its phosphorylated product PI 3,4,5-triphosphate 
(PI(3,4,5)P3) are two major phosphoinositides con-
centrated at the plasma membrane. Their levels, which 
are  tightly  controlled  by  kinases,  phospholipases,  and 
phosphatases, regulate a variety of cellular functions, in-
cluding clathrin-mediated endocytosis and receptor sig-
naling. In this study, we show that the inositol 5-phosphatase 
SHIP2, a negative regulator of PI(3,4,5)P3-dependent sig-
naling, also negatively regulates PI(4,5)P2 levels and is 
concentrated at endocytic clathrin-coated pits (CCPs) via 
interactions with the scaffold protein intersectin. SHIP2 is 
recruited early at the pits and dissociates before fission. 
Both knockdown of SHIP2 expression and acute produc-
tion of PI(3,4,5)P3 shorten CCP lifetime by enhancing the 
rate of pit maturation, which is consistent with a positive 
role of both SHIP2 substrates, PI(4,5)P2 and PI(3,4,5)P3, 
on coat assembly. Because SHIP2 is a negative regulator 
of insulin signaling, our findings suggest the importance 
of the phosphoinositide metabolism at CCPs in the regula-
tion of insulin signal output.
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clathrin-mRFP. Clathrin spots, shown previously to represent 
individual CCPs (Gaidarov et al., 1999; Zoncu et al., 2007), 
formed  continuously  at  the  plasma  membrane  and  abruptly   
disappeared as the result of fission and internalization. Their 
cumulative surface lifetimes were 1–2 min (Fig. 1, C and D), as 
we and others previously reported (Gaidarov et al., 1999; Perera 
et al., 2006). GFP-SHIP2 signal increased in parallel with clathrin-
mRFP fluorescence but plateaued earlier than clathrin and dis-
appeared slightly before clathrin (Fig. 1, C and D; and Video 1). 
Comparison of the dynamics of GFP-SHIP2 relative to cortactin-
DsRed, which visits late-stage CCPs together with dynamin just 
before fission (Merrifield et al., 2005), revealed that cortactin 
appeared just as SHIP2 disappeared (Fig. 1 E), confirming that 
SHIP2 leaves CCPs before fission. Collectively, these results 
demonstrate that SHIP2 is a component of early-stage CCPs.
The localization of SHIP2 at CCPs is 
mediated by its proline-rich region
The catalytic domain of SHIP2 (see domain structure in Fig. 2 A) is 
flanked at the C-terminal side by a proline-rich region followed 
by a SAM (sterile  motif) domain (Ooms et al., 2009). Deletion 
of the SAM domain did not affect CCP localization (Fig. S1 C).   
However, a SHIP2 construct lacking the proline-rich region no 
longer localized to CCPs (Fig. 2 B). This construct localized 
instead to focal adhesions, as verified by colocalization with the 
tip of actin stress fibers (Fig. 2 C), and Mena, a focal adhesion 
protein (Fig. S2 D; Krause et al., 2003). Thus, SHIP2 is recruited 
to CCPs through its proline-rich region, and when the targeting 
signal present in this domain is missing, another targeting sig-
nal that directs the protein to focal adhesion predominates. The 
small fraction of cells that normally exhibit preferential focal 
adhesion localization of full-length SHIP2 may reflect a differ-
ent functional state of these cells and suggests that the balance 
and OCRL (Perera et al., 2006; Erdmann et al., 2007; Mao   
et al., 2009), can act on PI(3,4,5)P3 in addition to PI(4,5)P2 
(Woscholski et al., 1997; Zhang et al., 1998; Ooms et al., 2009). 
Thus, PI(3,4,5)P3 may contribute to clathrin coat dynamics be-
sides having a role in signaling. Based on these considerations, 
we have investigated whether SHIP2, a broadly expressed inositol 
5-phosphatase whose preferred substrate is PI(3,4,5)P3 but can 
also act on PI(4,5)P2 (Hejna et al., 1995; Taylor et al., 2000), has 
a role at endocytic CCPs.
Results and discussion
SHIP2 is localized at endocytic CCPs
Total  internal  reflection  fluorescence  microscopy  (TIRFM)  of   
COS-7 cells cotransfected with GFP-SHIP2 and with an mRFP 
fusion of the clathrin light chain (clathrin-mRFP) revealed that 
in >95% of cells expressing GFP-SHIP2 at low levels, this pro-
tein appeared in small diffraction-limited spots that overlapped 
with clathrin puncta (Figs. 1 A and 2 A; Gaidarov et al., 1999).   
Accordingly, SHIP2 also colocalized with mRFP-tagged epsin, 
an endocytic clathrin adaptor (Fig. 1 B; Chen et al., 1998). More 
than 80% of endocytic CCPs were positive for SHIP2. Only in a 
minority of cells was SHIP2 localized instead to focal adhesions, 
which is consistent with the known interaction of SHIP2 with focal 
adhesion proteins such as p130
CAS and filamin (Dyson et al., 2001; 
Prasad et al., 2001). Both CCP and focal adhesion localizations 
of GFP-SHIP2 were observed in cells expressing higher levels   
of the protein. The presence of GFP-SHIP2 at CCPs was observed 
in all cells examined (C2C12, PtK2, mouse fibroblasts, and pri-
mary astrocytes; Fig. S1 A), whereas the highly homologous   
5-phosphatase SHIP1 did not localize to CCPs (not depicted).
The  dynamics  of  SHIP2  at  CCPs  were  analyzed  by   
TIRFM in COS-7 cells expressing low levels of GFP-SHIP2 and   
Figure  1.  Localization  of  SHIP2  at  CCPs.  
(A and B) TIRFM images of COS-7 cells express-
ing GFP-SHIP2 and either clathrin-mRFP (A) or 
mRFP-epsin (B). (A) Insets show the boxed areas 
at  high  magnification.  White  arrows  point  to 
SHIP2-positive CCPs, whereas red arrowheads 
point to SHIP2-negative CCPs. (C and D) Snap-
shots  of  clathrin-mRFP  and  GFP-SHIP2  fluores-
cence at a single CCP (C) and mean time course 
of  relative  fluorescence  intensity  at  CCPs  (D).   
(D) Error bars show mean ± SD. (E) Snapshots of 
GFP-SHIP2 and cortactin-DsRed fluorescence at 
a CCP. Bars: (A and B) 5 µm; (C and E) 1 µm.309 SHIP2 at clathrin-coated pits • Nakatsu et al.
which is consistent with a recent yeast two hybrid–based study of a 
direct interaction of SHIP2 with intersectin 1 (Xie et al., 2008), 
was confirmed by Western blotting of the affinity-purified 
material (Fig. 2 H).
Because intersectin 1 is a scaffold adaptor protein concen-
trated at CCPs (McPherson, 2002), its role in subcellular target-
ing of SHIP2 was investigated by TIRFM. In COS-7 cells, both 
GFP–intersectin 1–L and –S colocalized with clathrin-mRFP 
as expected (Fig. S2, A and B). SHIP2 also colocalized at 
these puncta (Fig. S2 C). However, when levels of intersectin 1 
were reduced by 90% via siRNA-mediated knockdown (KD;   
Fig. 2 I), SHIP2 localization at CCPs was no longer observed 
(Fig. 2 J), although the clathrin signal itself remained robust. 
Under these conditions, SHIP2 had a mainly diffuse localiza-
tion with some accumulation at focal adhesions. Because local-
ization of intersectin 1 at CCPs was not perturbed in SHIP2 KD 
between these two types of SHIP2 localizations may be regulated. 
Analysis of additional SHIP2 truncation mutants mapped the 
CCP localization signal to aa 1022–1078 (Fig. 2 D and Fig. S2 E). 
This region does not include known clathrin or clathrin adaptor 
binding motifs.
Binding of a polyproline motif of  
SHIP2 to intersectin is responsible for 
CCP localization
To identify protein interactors of the aa 1022–1078 region of 
SHIP2 that may be responsible for CCP localization, pull-down 
experiments from a rat brain cytosolic extract were performed. 
SDS-PAGE analysis of the material specifically affinity puri-
fied by GST–SHIP2-1022–1078 revealed 190- and 150-kD 
bands, which mass spectrometry identified as the long (L) and 
short (S) forms of intersectin 1 (Fig. 2 G). This identification, 
Figure 2.  The recruitment of SHIP2 to CCPs is mediated by intersectin. (A–F) COS-7 cells transiently expressing GFP fusions of SHIP2 constructs as indi-
cated together with either clathrin-mRFP or mCherry-actin. 5-Ptase, 5-phosphatase. (G) SDS-PAGE gel (Coomassie blue staining) of the material affinity 
purified from a rat brain extract by pull-downs with GST or GST–SHIP2-1022–1078 as indicated (ITSN-L and -S, long and short isoforms of intersectin).   
(H) Anti–intersectin 1 Western blotting of material pulled down from rat brain lysate with GST, GST–SHIP2-1022–1078 (WT) or GST–SHIP2-1022–1078 
with an F to A mutation at position 1054 (FA). The GST proteins used for the pull-down are shown below the Western blot (Coomassie blue staining). 
The dashed line indicates separate membranes. (I) Western blotting with anti–intersectin 1 or anti–glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
antibodies of COS-7 cells transfected with control siRNA (ctrl) or intersectin 1–specific siRNA (KD). (J) TIRFM image of COS-7 cell transfected with control 
siRNA (ctrl) or intersectin 1–specific siRNA (KD) transiently expressing GFP-SHIP2 and clathrin-mRFP. Bars, 5 µm.JCB • VOLUME 190 • NUMBER 3 • 2010   310
assay (Fig. 3 H). A physiological and major role of SHIP2 in the 
control of PI(4,5)P2 levels was supported by the finding that the 
PI bisphosphate (PIP2)/PI phosphate (PIP) ratio in SHIP2 KD 
cells was 40% higher than in control cells (Fig. 3 I). Thus, a 
potential explanation for the faster growth of endocytic CCPs   
in SHIP2 KD cells is that higher levels of PI(4,5)P2 promote a 
faster recruitment of the endocytic clathrin adaptors and their 
accessory proteins (Fig. 3, C–G).
Clathrin  adaptors  can  also  bind  PI(3,4,5)P3  (Gaidarov 
et al., 1996; Hao et al., 1997; Rapoport et al., 1997; Gaidarov 
and Keen, 1999; Itoh et al., 2001; Collins et al., 2002). How-
ever, PI(3,4,5)P3 levels were at the limit of detectability in both 
control and SHIP2 KD cells kept in normal serum-containing   
medium, unless cells were subjected to acute serum stimulation 
after serum deprivation. Under such conditions, a PI(3,4,5)P3 
peak was readily detected, and its levels were 20% higher in 
SHIP2 KD cells (Fig. 4 A). Thus, global changes in PI(3,4,5)P3 
levels are unlikely to account for changes in the dynamics of 
CCPs under our standard culture conditions. It remains possible 
that local pools of PI(3,4,5)P3 generated by PI 3-kinases local-
ized at CCPs may play a role in CCP dynamics and that im-
paired dephosphorylation of PI(3,4,5)P3 may contribute to the 
accelerated maturation of CCPs observed in SHIP2 KD cells. 
Type I PI 3-kinases are expected to be localized at endocytic 
CCPs that mediate the internalization of growth factor receptors 
(Cantley, 2002; Engelman et al., 2006). Furthermore, studies of 
type II PI 3-kinases  and  (PI3KC2- and PI3KC2-) have 
revealed links of these enzymes to CCPs. More specifically,   
(a) both PI3KC2- and PI3KC2- contain binding sites for   
endocytic clathrin coats (Engelman et al., 2006), (b) PI3KC2- 
was detected at CCPs (Gaidarov et al., 2001), and (c) PI3KC2-  
was shown to interact with SH3 domains of intersectin 1, an   
endocytic CCP component (Fig. S2; Das et al., 2007; Henne et al., 
2010). In fact, TIRFM analysis confirmed that both PI3KC2- 
and PI3KC2- localized at CCPs in COS-7 cells (Fig. S2, E and F).   
Although the main in vitro product of type II PI 3-kinases is   
PI 3-phosphate, it was reported that binding of PI3KC2- to 
clathrin modifies its substrate preference, thus enabling it to 
synthesize PI(3,4,5)P3 from PI(4,5)P2 (Gaidarov et al., 2001).
PI(3,4,5)P3 production accelerates 
endocytic CCP dynamics
Based on the aforementioned considerations, we tested directly the 
effect of PI(3,4,5)P3 on CCP dynamics. Because acute stimulation 
by serum or purified growth factors is expected not only to increase 
PI(3,4,5)P3 levels but also to affect the dynamics of proteins asso-
ciated with the plasma membrane indirectly, via the stimulation of 
tyrosine phosphorylation, we used a protocol selectively aimed at 
increasing PI(3,4,5)P3. More specifically, we used the rapamycin-
inducible FRB (FKBP12-rapamycin binding)-FKBP (FK506- 
binding protein) heterodimerization system to acutely recruit PI 3-
kinase to the plasma membrane (Fig. 4 B; Suh et al., 2006; Varnai 
et al., 2006; Zoncu et al., 2007). Plasma membrane–targeted CFP-
FRB was coexpressed in COS-7 cells together with RFP-FKBP (as 
a control) or with RFP-FKBP fused to the p110-binding domain 
(also called the inter-SH2 domain) of the p85 regulatory subunit of 
type I PI 3-kinase (RFP–FKBP-iSH2), which functions as a ligand 
cells (Fig. S2 D), these results indicate that intersectin 1 regu-
lates the CCP localization of SHIP2. This possibility is consis-
tent with the recent report that intersectin, as shown in this study 
for SHIP2 (Fig. 1), is an early component of CCPs that dissoci-
ates from them before fission (Henne et al., 2010).
Binding of SHIP2 to intersectin 1 was shown to involve its 
SH3 domains (Xie et al., 2008). Upon inspection of the 1022–1078 
aa sequence of SHIP2 for proline-based putative SH3-binding 
motifs  using  the  Eukaryotic  Linear  Motif  server  (http://elm 
.eu.org/) and SH3-Hunter websites (http://cbm.bio.uniroma2.it/
SH3-Hunter/), several candidate SH3-binding sites were identi-
fied, including the motif PPPDF (aa 1050–1054), which is simi-
lar to the previously recognized SH3 binding motif PPPDY 
(Mongioví et al., 1999). Pull-downs with GST–SHIP2-1022–
1078 from brain extracts revealed that intersectin binding was 
disrupted by an F to A mutation at position 1054 (Fig. 2 H). 
Moreover, full-length GFP–SHIP2-F1054A mutant did not lo-
calize at CCPs (Fig. 2 E) and produced the focal adhesion pat-
tern as well as a diffuse localization (Fig. 2 F). We conclude that 
the sequence of SHIP2 centered around the PPPDF sequence 
plays a key role in the localization of SHIP2 to CCPs.
SHIP2 is a negative regulator of  
CCP growth
We next explored a potential role of SHIP2 on CCP dynamics. 
COS-7 cells were stably transfected with control short hairpin 
RNA (shRNA) or shRNA directed against SHIP2 to knock down 
this phosphatase (Fig. 3 A). TIRFM of these cells after transient 
expression of GFP–clathrin light chain revealed that the mean 
CCP lifetime in SHIP2 KD cells (77 s; n = 1,648; Fig. 3 B, red; 
and Video 2) was 25% shorter than in control cells (102 s; n = 697;   
Fig. 3 B, blue; and Video 3). This change was accounted for, 
at least in part, by a faster rate of increase in the GFP-clathrin 
signal (Fig. 3 C), suggesting that SHIP2 negatively regulates the 
speed of maturation of CCPs.
Similar results were obtained by monitoring the effect 
of SHIP2 KD on the recruitment to the pits of three clathrin 
adaptors. The adaptor AP-2, as demonstrated by imaging its 
GFP-tagged 2 subunit, and the monomeric adaptors epsin1 
(epsin1-GFP) and CALM (clathrin assembly lymphoid myeloid 
leukemia; GFP-CALM) accumulated more rapidly and peaked 
earlier at CCPs of SHIP2 KD cells than in control cells (Fig. 3, 
D–F), with a time course that precisely paralleled that of clath-
rin (Fig. S3). An earlier recruitment to the CCPs was also ob-
served for dynamin (dynamin-GFP; Fig. 3 G), a critical factor 
for endocytic CCP fission, which is consistent with the overall 
shorter lifetime of the CCPs.
SHIP2 and phosphoinositide levels
PI(4,5)P2, which binds all endocytic clathrin adaptors as well as 
dynamin, is a master regulator of endocytic clathrin coat assem-
bly (Gaidarov and Keen, 1999; Ford et al., 2001; Collins et al., 
2002; Haucke, 2005; Zoncu et al., 2007; Thieman et al., 2009). 
Although the preferred substrate for the inositol 5-phosphatase 
activity of SHIP2 was reported to be PI(3,4,5)P3 (Damen et al., 
1996; Pesesse et al., 1998), PI(4,5)P2 is also a substrate (Taylor 
et al., 2000), as we have confirmed by an in vitro phosphatase 311 SHIP2 at clathrin-coated pits • Nakatsu et al.
membrane accelerate CCP growth and turnover. Furthermore, the 
lifetime of CCPs was even faster (92 s; n = 30; Fig. 4 D, green) 
at the membrane ruffles (Video 4), i.e., sites where the concentra-
tion of GFP-Akt-PH, and thus PI(3,4,5)P3, in the membrane is the 
highest. Collectively, these results suggest that dephosphoryla-
tion of PI(3,4,5)P3, in addition to dephosphorylation of PI(4,5)P2, 
is a mechanism through which SHIP2 controls CCP dynamics 
and increased levels of either of these phosphoinositides leads to 
accelerated CCP turnover.
Concluding remarks
Collectively, these results demonstrate that SHIP2 has an im-
portant function in coat dynamics and signaling at endocytic 
CCPs, where intersectin plays a major role in its recruitment. 
for the endogenous p110 catalytic subunit of the kinase. Addition   
of the rapamycin analogue iRAP (indole-modified analogue of 
rapamycin) induced a robust translocation of RFP-FKBP (not 
depicted) or RFP–FKBP-iSH2 to the plasma membrane, as ex-
pected (Fig. 4 C). However, only in cells expressing RFP–FKBP-
iSH2,  and  not  in  cells  expressing  RFP-FKBP  (not  depicted), 
were a recruitment of the PI(3,4,5)P3 reporter GFP-Akt–pleck-
strin homology (PH) to the plasma membrane and formation 
of ruffles also observed, indicating production of PI(3,4,5)P3 
in this membrane (Fig. 4 C). In cells expressing RFP–FKBP-
iSH2 and treated with iRAP, the mean CCP lifetime (115 s;   
n = 227; Fig. 4 D, red) was 20% shorter than in control cells 
expressing RFP-FKBP (149 s; n = 186; Fig. 4 D, blue), support-
ing the hypothesis that higher levels of PI(3,4,5)P3 in the plasma 
Figure 3.  Loss of SHIP2 affects PI(4,5)P2 levels and accelerates endocytic CCP dynamics. (A) Anti-SHIP2 and anti–-actin Western blots of COS-7 cells 
stably expressing control shRNA (ctrl) or SHIP2-specific shRNA (SHIP2 KD). (B) Cumulative histograms of CCP lifetime (GFP–clathrin light chain signal) in 
control cells (n = 697) and SHIP2 KD cells (n = 1,648). (C) Time course of relative fluorescence intensity of GFP-clathrin in control cells and SHIP2 KD cells. 
(D–G) Time course of relative fluorescence intensity of mRFP and GFP fluorescence in cells double transfected with clathrin-mRFP and with GFP fusions of 
clathrin adaptors and dynamin as indicated. (H, top) PI(4,5)P2 and PI(3,4,5)P3 phosphatase activity (Malachite green assay) in anti-GFP immunoprecipitates 
from COS-7 cells expressing GFP, GFP-SHIP2, or GFP–SHIP2-D608A (catalytically dead). (bottom) Anti-GFP Western blot of the material used in the phos-
phatase assay. (I) PIP2/PIP ratio in control and SHIP2 KD cells as determined by HPLC (*, P < 0.05; t test). (C–I) Error bars show mean ± SD.JCB • VOLUME 190 • NUMBER 3 • 2010   312
PI(4,5)P2  and  PI(3,4,5)P3,  is  recruited  to  CCPs  only  at  late 
stages and remains associated with newly formed endocytic 
vesicles (Fig. 5; Erdmann et al., 2007). Thus, it would appear 
that CCP turnover and signaling involve sequential and co-
ordinated actions of multiple inositol 5-phosphatases. The rela-
tive importance of each inositol 5-phosphatase likely differs in 
different cell types, given the heterogeneous expression of these 
enzymes across tissues.
Overall, an important role in endocytic clathrin coat   
dynamics and signaling appears to be a shared, evolutionary 
conserved function of several inositol 5-phospahtases. The en-
zymes that synthesize the substrates of these phosphatases, i.e., 
PI(4,5)P2 and PI(3,4,5)P3, also have links to endocytic clathrin 
coats. More specifically, all three type I PIP kinases, i.e., the 
PI 4-phosphate 5-kinases which are responsible for the bulk of 
PI(4,5)P2 synthesis in mammals (Heck et al., 2007; Volpicelli-
Daley  et  al.,  2010),  can  interact  with  the  endocytic  clathrin 
adaptor AP-2 (with the  isoform having additional high affin-
ity binding sites for such adaptors; Bairstow et al., 2006; Krauss   
et al., 2006; Thieman et al., 2009). As discussed in this study, 
PI 3-kinases are also recruited to endocytic clathrin coats, al-
though their contribution to the endocytic CCP dynamics at 
steady-state might be minimal because wortmannin, an inhibi-
tor for PI 3-kinases, hardly affected the dynamics (Fig. S3 E; 
Shpetner et al., 1996).
The  action  of  SHIP2  is  important  for  attenuation  of   
insulin-mediated signaling. Thus, endocytic CCPs represent 
Based on the impact of SHIP2 depletion on total PI(4,5)P2 lev-
els, at least some of these effects are likely to be mediated by its 
property to dephosphorylate PI(4,5)P2 in addition to PI(3,4,5)P3. 
PTEN, the other negative regulator of PI(3,4,5)P3 signaling, does 
not act on PI(4,5)P2 (Maehama and Dixon, 1999), which may 
account for some of the different physiological actions of PTEN 
and SHIP2.
The previously unknown robust effect of SHIP2 in the 
regulation of PI(4,5)P2 levels raises the possibility that a reduc-
tion in the availability of this substrate for PI 3-kinases may 
contribute to the negative effect of SHIP2 on PI(3,4,5)P3 signal-
ing.  The  faster  maturation  and  shorter  lifetime  of  CCPs  in 
SHIP2 KD cells not only agrees with a role of PI(4,5)P2 and 
possibly PI(3,4,5)P3 in their dynamics but also supports the occur-
rence of phosphoinositide turnover at CCPs, as first suggested 
by the early recruitment at pits of another inositol 5-phosphatase, 
synaptojanin-170 (Fig. 5; Perera et al., 2006). Like SHIP2, syn-
aptojanin can act both on PI(4,5)P2 and PI(3,4,5)P3 (Woscholski 
et al., 1997; Cremona et al., 1999; Mani et al., 2007). Because 
SHIP2 is recruited to CCPs from the initial stages but leaves be-
fore fission, it most likely controls only growth and/or matura-
tion of CCPs, whereas synaptojanin-170 is also implicated in 
late endocytic steps, including clathrin uncoating after fission 
(Fig. 5; Perera et al., 2006). Interestingly, intersectin also binds 
synaptojanin (McPherson, 2002), although it does not appear   
to have a dominant role in the recruitment of this protein to 
CCPs. OCRL, another inositol 5-phosphatase that acts on both 
Figure  4.  PI(3,4,5)P3  production  acceler-
ates  endocytic  CCP  dynamics.  (A)  Ratio  of 
PI(3,4,5)P3 to total inositol phospholipids (PIs) 
in control and SHIP2 KD cells after serum stimu-
lation as determined by HPLC. Error bars show 
mean ± SD (*, P < 0.05; t test). (B) Schematic 
representation  of  the  rapamycin-inducible   
heterodimerization system used to recruit a PI   
3-kinase at the plasma membrane. (C) COS-7 
cells expressing RFP–FKBP-iSH2 or GFP-Akt-PH 
in the absence or presence of the rapamycin 
analogue (RAPA). (D) Cumulative histograms 
of CCP lifetime in cells expressing RFP-FKBP   
(n  =  186;  blue),  RFP–FKBP-iSH2  (n  =  227; 
red), or RFP–FKBP-iSH2 in ruffle (n = 30; green).   
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sample buffer and separated by SDS-PAGE. Protein identification by 
liquid  chromatography–mass  spectrometry  was  performed  at  Keck   
Research Facility at Yale University.
RNA interference and stable cell lines
COS-7 cell lines expressing either control shRNA vector (pRS-shGFP) or 
pRS vector encoding SHIP2-specific shRNA were established and main-
tained in the presence of puromycin. For intersectin KD, COS-7 cells were 
transfected with either control siRNA or stealth siRNA directed against   
intersectin 1 (Invitrogen) using RNAiMAX reagent (Invitrogen).
TIRFM
Image acquisition was performed as described previously (Perera et al., 
2006). In brief, cells were imaged at 37°C by TIRFM using an objective-
type inverted microscope (IX-70; Olympus) fitted with a 60× NA 1.45 
TIRFM lens (Olympus) and controlled by iQ software (Andor Technology). 
Laser lines (488 and 568 nm) from argon and argon/krypton lasers (CVI 
Melles Griot) were coupled to the TIRFM condenser through a single op-
tical fiber. The calculated evanescent field depth was 100 nm. Cells 
were typically imaged in two channels by sequential excitation at 0.25   
Hz, without binning, with 0.2–0.5-s exposures and detected with a back- 
illuminated  electron-multiplying  charge-coupled  device  camera  (512  × 
512 pixels; 16-bit; iXon887; Andor Technology).
Rapalogue-induced PI(3,4,5)P3 production
COS-7 cells expressing optimal levels of each marker (clathrin-GFP, plasma 
membrane–FRB-CFP  [Varnai  et  al.,  2006;  Zoncu  et  al.,  2007],  and   
mRFP-FKBP or mRFP–FKBP-iSH2) were preselected using wide-field epi-
fluorescence, after which the imaging modality was switched to TIRFM. 
Clathrin-GFP and mRFP-FKBP or mRFP–FKBP-iSH2 were imaged by sequential 
illumination at 488-nm and 568-nm, respectively. After an initial imaging 
period of 7–10 min, rapalogue (Zoncu et al., 2007) was added to cells   
(5 µM iRAP or 500 nM AP021967), and imaging was continued for an 
additional 20 min. Successful membrane recruitment of mRFP–FKBP-iSH2 
was indicated by an increase in 568-nm fluorescence by TIRFM.
Image analysis
Image analysis was performed using ImageJ (National Institutes of Health) 
and iQ software as described previously (Perera et al., 2006). CCPs were 
randomly selected, and for each time point, the fluorescence intensity was 
normalized to the peak fluorescence intensity of that pit. Colocalization 
analysis was performed as described previously (Perera et al., 2006). For 
graphs of fluorescence intensity, we analyzed at least 12 CCPs from at 
least three cells. For histograms of CCP lifetime, we analyzed at least 186 
CCPs from at least three cells.
Phosphoinositide analysis
Levels of phosphoinositides were analyzed by separating glycerol-inositol 
phosphates with HPLC after phospholipid deacylation. For the analysis of 
major sites where the functions of phosphoinositide metabolism 
in membrane dynamics and signaling are integrated. Because 
SHIP2 is a promising target for therapeutic interventions aimed 
at restoring insulin sensitivity in type II diabetes (Lazar and 
Saltiel, 2006; Suwa et al., 2009), our findings, which define a 
critical site of action of SHIP2, may have implications toward 
the development of drugs that may help treat this disease.
Materials and methods
Plasmids and reagents
Sources of cDNAs were as follows: GFP-(mouse)SHIP2 from U. Phillippar 
(Massachusetts Institute of Technology, Cambridge, MA); cortactin-DsRed 
from M. Kaksonen (European Molecular Biology Laboratory, Heidelberg, 
Germany);  clathrin-GFP  (LCa-GFP)  from  J.  Keen  (Thomas  Jefferson  Uni-
versity, Philadelphia, PA); GFP–intersectin 1–L and –S from P. McPherson   
(McGill University, Montreal, Quebec, Canada); mRFP-epsin from H. Chen 
(De Camilli laboratory); epsin-GFP from G. Ko (De Camilli laboratory); 
clathrin-mRFP (LCa-mRFP) from the De Camilli laboratory (Zoncu et al., 
2007); 2-GFP and GFP-CALM from A. Sorkin (University of Pittsburgh, 
Pittsburgh, PA); and dynamin-GFP from M. McNiven (Mayo Clinic, Roch-
ester, MN). SHIP2 mutants were generated by PCR, PCR-based mutagen-
esis (Nakatsu et al., 2000) or the QuikChange kit (Agilent Technologies). 
mCherry-actin was constructed by PCR. mCherry-SHIP2 was made by re-
placing GFP with mCherry in the GFP-SHIP2 plasmid. To generate mRFP–
FKBP-iSH2, the inter-SH2 domain of the p85 regulatory subunit of human 
class I PI 3-kinase was amplified by PCR and inserted at the C-terminal 
side of the FKBP module in the mRFP-FKBP backbone vector (Zoncu et al., 
2007). HuSH 29-mer SHIP2-specific shRNA and control shRNA constructs 
were purchased from OriGene Technologies.
Anti–intersectin 1 antibodies were provided by P. McPherson. The fol-
lowing antibodies were purchased: anti-GFP antibodies from Takara Bio Inc. 
and Invitrogen and anti–-actin from Sigma-Aldrich. Anti-SHIP2 polyclonal an-
tibodies were obtained by immunizing rabbits with a human SHIP2 fragment 
corresponding to aa 887–1019 and then affinity purified with protein G– 
Sepharose (GE Healthcare) by T. Itoh in the De Camilli laboratory.
GST pull-down
GST  pull-downs  were  performed  as  described  previously  (Erdmann   
et  al.,  2007).  In  brief,  GST,  GST–SHIP2-1022–1078,  or  GST–SHIP2-
1022–1078-F1054A  recombinant  proteins  were  purified  from  Esch-
erichia coli using glutathione-Sepharose beads (GE Healthcare). Proteins 
immobilized on the beads were subsequently incubated with a rat brain 
extract generated by lysing brain tissue in lysis buffer (PBS containing 
1% Triton X-100) for 2 h at 4°C, followed by extensive washes with lysis 
buffer and PBS. Proteins retained on beads were eluted with SDS-PAGE   
Figure 5.  Inositol 5-phosphatases at endocytic CCPs. Schematic cartoon showing that different inositol 5-phosphatases associate with endocytic CCPs at 
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with [
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In vitro phosphatase assay
The in vitro phosphatase assay (malachite assay) to monitor the enzymatic 
activity of SHIP2 against PI(4,5)P2 and PI(3,4,5)P3 was performed as de-
scribed previously (Mani et al., 2007). In brief, COS-7 cells expressing 
GFP, GFP-SHIP2, or GFP–SHIP2-D608A were extracted in lysis buffer, and 
transfected proteins were purified by immunoprecipitation with protein G–
Sepharose-immobilized anti-GFP antibodies. Aliquots of the immunoprecipi-
tates were then either analyzed by Western blotting to confirm consistent 
recovery of transfected proteins or incubated with a water-soluble phospho-
inositide substrate (with a diC8-acyl chain; Echelon) for 30 min at 37°C. 
Aliquots of the bead supernatant at the end of this incubation were mixed 
with malachite-green solution, and released free phosphate was measured 
by a plate reader at 650-nm wavelength (Lee et al., 2004). Data show 
mean ± SD of three independent experiments.
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the localization of intersectin, SHIP2, PI3KC2-, and PI3KC2- at CCPs 
and shows that targeting of intersectin to CCPs is independent of SHIP2. 
Fig. S3 shows the time course of the fluorescence intensity of clathrin-
mRFP and GFP-tagged clathrin adaptors or dynamin at CCPs and that 
wortmannin has no effect on clathrin lifetime. Video 1 shows the dynamics 
of GFP-SHIP2 and clathrin-mRFP in COS-7 cells. Videos 2 and 3 show 
the dynamics of clathrin-GFP in control and SHIP2 KD cells, respectively.   
Video 4 shows the dynamics of clathrin-GFP within a ruffle of a FKBP-iSH2–
expressing cell. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201005018/DC1.
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